Literature DB >> 33444778

Transition Care from Adolescence to Adulthood: A 10-Year Service Review of the Gynecological Implications for Young Women and Girls Born with Cloacal Anomalies.

Ursula E B Blyth1, Anupam Lall2, Bruce Jaffray2, Meenakshi Choudhary3.   

Abstract

STUDY
OBJECTIVE: To establish the gynecological and reproductive outcomes for girls born with a cloacal anomaly, seen in a pediatric specialist cloaca clinic.
DESIGN: Local approval was granted to conduct this review. Outcomes were retrospectively identified using healthcare records. PARTICIPANTS: Girls with known cloacal anomaly, seen in the cloaca clinic between 2009 and 2019, who had attained menarche or received gynecological input.
RESULTS: Nine females met the inclusion criteria, who were 12-30 years old. The mean age of menarche was 12 years (SD = 1.29). Two developed obstructed menstruation, requiring surgical intervention. Vaginal stenosis affected all women. Three women underwent revision surgery, and 1 is awaiting surgery. None of the women have attempted a pregnancy, to our knowledge.
CONCLUSION: Cloacal anomaly is a rare complex condition. Female individuals with cloacal anomaly require multidisciplinary gynecology specialist care throughout adolescence and adulthood. Provision of a dedicated gynecological service could improve the quality of life of these women. Crown
Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cloaca; Congenital anomaly; Gynecological anomaly; Gynecological outcome; Mullerian anomaly; Reproductive outcome

Year:  2021        PMID: 33444778     DOI: 10.1016/j.jpag.2021.01.001

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  1 in total

1.  Pelvic exams and cervical cancer screening in patients with anorectal malformations.

Authors:  Lea A Wehrli; Andrea Bischoff; Luis De La Torre; Marina L Reppucci; Jill Ketzer; Alberto Peña; Veronica I Alaniz
Journal:  Pediatr Surg Int       Date:  2022-09-15       Impact factor: 2.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.